{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:25:44Z","timestamp":1792506344844,"version":"4.5.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004361","name":"Krebsliga Schweiz","doi-asserted-by":"publisher","award":["KFS-6522-08-2025"],"award-info":[{"award-number":["KFS-6522-08-2025"]}],"id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["171037"],"award-info":[{"award-number":["171037"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002300","name":"Rivkin Center for Ovarian Cancer","doi-asserted-by":"publisher","award":["836897"],"award-info":[{"award-number":["836897"]}],"id":[{"id":"10.13039\/100002300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In women with high-grade serous ovarian cancer, chemotherapy remains the primary standard treatment, despite growing recognition of the disease as highly heterogeneous. Here, we examine the feasibility and clinical utility of comprehensive multimodal molecular profiling to inform treatment decisions. We analyze blood, single-cell and bulk tumor tissue, and malignant ascites using up to eleven technologies (DNA, RNA, protein, and functional assays) within a four-week turnaround time. Hypothetical treatment recommendations are altered for 76% of patients, and multi-omics-guided maintenance therapy is associated with prolonged overall survival in a subset of patients. Subsequent cohort analysis reveals distinct cellular and molecular profiles in ascites-derived single-cells compared to solid tumor tissue, unique per-patient ex vivo drug responses, and a marked increase in cancer cell heterogeneity following chemotherapy exposure. This coincides with genomic signature alterations in whole-genome-amplified patients. Our data suggest that molecularly guided treatments should be tested as adjuvant therapies prior to chemotherapy in the future.<\/jats:p>","DOI":"10.1038\/s41467-026-74585-w","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:43:27Z","timestamp":1783971807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0446-1942","authenticated-orcid":false,"given":"Francis","family":"Jacob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9616-3303","authenticated-orcid":false,"given":"Rebekka","family":"Wegmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Ficek-Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Lischetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5357-2705","authenticated-orcid":false,"given":"Jack","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Chevrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9896-3929","authenticated-orcid":false,"given":"Michael","family":"Prummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7911-7647","authenticated-orcid":false,"given":"Nora C.","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7849-3958","authenticated-orcid":false,"given":"Ilaria","family":"Alborelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9340-3612","authenticated-orcid":false,"given":"Ricardo","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6880-8020","authenticated-orcid":false,"given":"Sandra","family":"Goetze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Gut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica-Andreea","family":"Baciu-Dr\u0103gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0691-0489","authenticated-orcid":false,"given":"Anne","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4950-6825","authenticated-orcid":false,"given":"Ximena","family":"Bonilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Brugger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9236-1377","authenticated-orcid":false,"given":"Magdalena M.","family":"Brune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Calgua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Engler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro F.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio C.","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Malsot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8040-810X","authenticated-orcid":false,"given":"Julien","family":"Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Miglino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela S.","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9656-1416","authenticated-orcid":false,"given":"Jacobo","family":"Sarabia Del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujana","family":"Sivapatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina A.","family":"Sobottka-Brillout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanmay","family":"Tanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor A.","family":"Zwimpfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The TumorProfiler Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melike","family":"Ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal S.","family":"Al-Quaddoomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana I.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Albinus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Andani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Olof","family":"Attinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica-Andreea","family":"Baciu-Dra\u0306gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Baumhoer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Beck-Schimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Bodenmiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena","family":"Bonilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bosshard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Chevrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Chicherova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"D\u2019Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Danenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie R.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Erkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Eschbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Fedier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Ficek-Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja L.","family":"Frei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Goetze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Grob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Gut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirmin","family":"Haeuptle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Heinzelmann-Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Herter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Holtackers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Huesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Immer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Irmisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim M.","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Jahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alva R.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Jermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Kahles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Kahraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Kuebler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Kunze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kurzeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjong-Van","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Lischetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio C.","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Lugert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Maass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Markolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Mehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian M.","family":"Metzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Miglino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela S.","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Moch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Murri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte KY","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Nicolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Nunez","family":"Lop\u00e9z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick GA","family":"Pedrioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Pelkmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Piscuoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Pr\u00e9lot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Rimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L.","family":"Rosano-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"R\u00e4tsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Santacroce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobo Sarabia","family":"del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Schlenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra C.","family":"Schwalie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin","family":"Schwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Sch\u00e4r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Senti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenguang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Sobottka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipin T.","family":"Sreedharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Stekhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanmay","family":"Tanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre PA","family":"Theocharides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinu M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinko","family":"Tosevski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora C.","family":"Toussaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa A.","family":"Tuncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Tusup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Van Drogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Vlajnic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter P.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Wendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Wey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattheus HE","family":"Wildschut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Wollscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zoche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Zuend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9576-3267","authenticated-orcid":false,"given":"Rudolf","family":"Aebersold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Bacac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0573-6119","authenticated-orcid":false,"given":"Niko","family":"Beerenwinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5360-2193","authenticated-orcid":false,"given":"Christian","family":"Beisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Bodenmiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9206-4885","authenticated-orcid":false,"given":"Viktor H.","family":"Koelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjong-Van","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5902-9420","authenticated-orcid":false,"given":"Mitchell P.","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7986-2839","authenticated-orcid":false,"given":"Holger","family":"Moch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Muenst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Pelkmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4676-7931","authenticated-orcid":false,"given":"Markus G.","family":"Manz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"R\u00e4tsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6017-1595","authenticated-orcid":false,"given":"Franziska","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berend","family":"Snijder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1535-8692","authenticated-orcid":false,"given":"Alexandre P. A.","family":"Theocharides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Tolnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2924-8080","authenticated-orcid":false,"given":"Andreas","family":"Wicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3923-1610","authenticated-orcid":false,"given":"Bernd","family":"Wollscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Heinzelmann-Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"74585_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01102-1","volume":"14","author":"E Fountzilas","year":"2022","unstructured":"Fountzilas, E., Tsimberidou, A. M., Vo, H. H. & Kurzrock, R. Clinical trial design in the era of precision medicine. Genome Med. 14, 101 (2022).","journal-title":"Genome Med."},{"key":"74585_CR2","doi-asserted-by":"publisher","unstructured":"Tsimberidou, A.-M. et al. Initiative for molecular profiling and advanced cancer therapy (IMPACT): an MD anderson precision medicine study. JCO Precis. Oncol. 2017, https:\/\/doi.org\/10.1200\/po.17.00002 (2017).","DOI":"10.1200\/po.17.00002"},{"key":"74585_CR3","doi-asserted-by":"publisher","unstructured":"Chen, A. P. et al. Molecular profiling-based assignment of cancer therapy (NCI-MPACT): a randomized multicenter phase II trial. JCO Precis. Oncol. 5, https:\/\/doi.org\/10.1200\/po.20.00372 (2021).","DOI":"10.1200\/po.20.00372"},{"key":"74585_CR4","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/S1470-2045(15)00188-6","volume":"16","author":"C Le Tourneau","year":"2015","unstructured":"Le Tourneau, C. et al. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. Lancet Oncol. 16, 1324\u20131334 (2015).","journal-title":"Lancet Oncol."},{"key":"74585_CR5","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1158\/1078-0432.CCR-21-3752","volume":"28","author":"LR Hoes","year":"2022","unstructured":"Hoes, L. R. et al. Patients with rare cancers in the drug rediscovery protocol (DRUP) benefit from genomics-guided treatment. Clin. Cancer Res. 28, 1402\u20131411 (2022).","journal-title":"Clin. Cancer Res."},{"key":"74585_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41591-019-0407-5","volume":"25","author":"JK Sicklick","year":"2019","unstructured":"Sicklick, J. K. et al. Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study. Nat. Med. 25, 744\u2013750 (2019).","journal-title":"Nat. Med."},{"key":"74585_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-00969-w","volume":"13","author":"JK Sicklick","year":"2021","unstructured":"Sicklick, J. K. et al. Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-na\u00efve study. Genome Med. 13, 155 (2021).","journal-title":"Genome Med."},{"key":"74585_CR8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41591-019-0424-4","volume":"25","author":"J Rodon","year":"2019","unstructured":"Rodon, J. et al. Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial. Nat. Med. 25, 751\u2013758 (2019).","journal-title":"Nat. Med."},{"key":"74585_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18613-3","volume":"11","author":"S Kato","year":"2020","unstructured":"Kato, S. et al. Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy. Nat. Commun. 11, 4965 (2020).","journal-title":"Nat. Commun."},{"key":"74585_CR10","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1158\/2159-8290.CD-21-0126","volume":"11","author":"P Horak","year":"2021","unstructured":"Horak, P. et al. Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers. Cancer Discov. 11, 2780\u20132795 (2021).","journal-title":"Cancer Discov."},{"key":"74585_CR11","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.annonc.2023.07.011","volume":"34","author":"A Gonz\u00e1lez-Mart\u00edn","year":"2023","unstructured":"Gonz\u00e1lez-Mart\u00edn, A. et al. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann. Oncol. 34, 833\u2013848 (2023).","journal-title":"Ann. Oncol."},{"key":"74585_CR12","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S1470-2045(21)00531-3","volume":"22","author":"S Banerjee","year":"2021","unstructured":"Banerjee, S. et al. Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1\/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 22, 1721\u20131731 (2021).","journal-title":"Lancet Oncol."},{"key":"74585_CR13","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.annonc.2023.05.005","volume":"34","author":"I Ray-Coquard","year":"2023","unstructured":"Ray-Coquard, I. et al. Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1\/ENGOT-ov25 trial. Ann. Oncol. 34, 681\u2013692 (2023).","journal-title":"Ann. Oncol."},{"key":"74585_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.04.024","volume":"189","author":"A Gonz\u00e1lez-Mart\u00edn","year":"2023","unstructured":"Gonz\u00e1lez-Mart\u00edn, A. et al. Progression-free survival and safety at 3.5years of follow-up: results from the randomised phase 3 PRIMA\/ENGOT-OV26\/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer. Eur. J. Cancer 189, 112908 (2023).","journal-title":"Eur. J. Cancer"},{"key":"74585_CR15","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1056\/NEJMoa1909707","volume":"381","author":"RL Coleman","year":"2019","unstructured":"Coleman, R. L. et al. Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer. N. Engl. J. Med. 381, 2403\u20132415 (2019).","journal-title":"N. Engl. J. Med."},{"key":"74585_CR16","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","volume":"381","author":"I Ray-Coquard","year":"2019","unstructured":"Ray-Coquard, I. et al. Olaparib plus bevacizumab as first-line maintenance in ovarian cancer. N. Engl. J. Med. 381, 2416\u20132428 (2019).","journal-title":"N. Engl. J. Med."},{"key":"74585_CR17","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1056\/NEJMoa1611310","volume":"375","author":"MR Mirza","year":"2016","unstructured":"Mirza, M. R. et al. Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer. N. Engl. J. Med. 375, 2154\u20132164 (2016).","journal-title":"N. Engl. J. Med."},{"key":"74585_CR18","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMoa1910962","volume":"381","author":"A Gonz\u00e1lez-Mart\u00edn","year":"2019","unstructured":"Gonz\u00e1lez-Mart\u00edn, A. et al. Niraparib in patients with newly diagnosed advanced ovarian cancer. N. Engl. J. Med. 381, 2391\u20132402 (2019).","journal-title":"N. Engl. J. Med."},{"key":"74585_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47271-y","volume":"15","author":"E Denisenko","year":"2024","unstructured":"Denisenko, E. et al. Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones. Nat. Commun. 15, 2860 (2024).","journal-title":"Nat. Commun."},{"key":"74585_CR20","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.ccell.2023.04.017","volume":"41","author":"A Lahtinen","year":"2023","unstructured":"Lahtinen, A. et al. Evolutionary states and trajectories characterized by distinct pathways stratify patients with ovarian high grade serous carcinoma. Cancer Cell 41, 1103\u20131117.e12 (2023).","journal-title":"Cancer Cell"},{"key":"74585_CR21","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41571-023-00819-1","volume":"20","author":"AC Veneziani","year":"2023","unstructured":"Veneziani, A. C. et al. Heterogeneity and treatment landscape of ovarian carcinoma. Nat. Rev. Clin. Oncol. 20, 820\u2013842 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"74585_CR22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrc3144","volume":"11","author":"S Vaughan","year":"2011","unstructured":"Vaughan, S. et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat. Rev. Cancer 11, 719\u2013725 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"74585_CR23","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41568-022-00503-z","volume":"22","author":"LE Kandalaft","year":"2022","unstructured":"Kandalaft, L. E., Dangaj Laniti, D. & Coukos, G. Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation. Nat. Rev. Cancer 22, 640\u2013656 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"74585_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrc3711","volume":"14","author":"KT Bieging","year":"2014","unstructured":"Bieging, K. T., Mello, S. S. & Attardi, L. D. Unravelling mechanisms of p53-mediated tumour suppression. Nat. Rev. Cancer 14, 359\u2013370 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"74585_CR25","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/ng.2762","volume":"45","author":"G Ciriello","year":"2013","unstructured":"Ciriello, G. et al. Emerging landscape of oncogenic signatures across human cancers. Nat. Genet. 45, 1127\u20131133 (2013).","journal-title":"Nat. Genet."},{"key":"74585_CR26","doi-asserted-by":"publisher","unstructured":"Hirata, E. & Sahai, E. Tumor microenvironment and differential responses to therapy. Cold Spring Harb. Perspect. Med. 7, https:\/\/doi.org\/10.1101\/cshperspect.a026781 (2017).","DOI":"10.1101\/cshperspect.a026781"},{"key":"74585_CR27","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.cell.2014.06.049","volume":"158","author":"KA Hoadley","year":"2014","unstructured":"Hoadley, K. A. et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158, 929\u2013944 (2014).","journal-title":"Cell"},{"key":"74585_CR28","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ccell.2021.01.004","volume":"39","author":"A Irmisch","year":"2021","unstructured":"Irmisch, A. et al. The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support. Cancer Cell 39, 288\u2013293 (2021).","journal-title":"Cancer Cell"},{"key":"74585_CR29","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00428-018-2485-z","volume":"474","author":"VH Koelzer","year":"2019","unstructured":"Koelzer, V. H., Sirinukunwattana, K., Rittscher, J. & Mertz, K. D. Precision immunoprofiling by image analysis and artificial intelligence. Virchows Arch. 474, 511\u2013522 (2019).","journal-title":"Virchows Arch."},{"key":"74585_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s42255-022-00720-8","volume":"5","author":"P Forny","year":"2023","unstructured":"Forny, P. et al. Integrated multi-omics reveals anaplerotic rewiring in methylmalonyl-CoA mutase deficiency. Nat. Metab. 5, 80\u201395 (2023).","journal-title":"Nat. Metab."},{"key":"74585_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1158\/1078-0432.CCR-23-0562","volume":"30","author":"N Zila","year":"2024","unstructured":"Zila, N. et al. Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 Therapy. Clin. Cancer Res. 30, 159\u2013175 (2024).","journal-title":"Clin. Cancer Res."},{"key":"74585_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12014-022-09349-x","volume":"19","author":"S Goetze","year":"2022","unstructured":"Goetze, S. et al. Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer. Clin. Proteomics 19, 9 (2022).","journal-title":"Clin. Proteomics"},{"key":"74585_CR33","doi-asserted-by":"publisher","first-page":"100060","DOI":"10.1016\/j.esmoop.2021.100060","volume":"6","author":"L De Mattos-Arruda","year":"2021","unstructured":"De Mattos-Arruda, L. & Siravegna, G. How to use liquid biopsies to treat patients with cancer. ESMO Open 6, 100060 (2021).","journal-title":"ESMO Open"},{"key":"74585_CR34","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.annonc.2022.05.520","volume":"33","author":"J Pascual","year":"2022","unstructured":"Pascual, J. et al. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. Ann. Oncol. 33, 750\u2013768 (2022).","journal-title":"Ann. Oncol."},{"key":"74585_CR35","doi-asserted-by":"publisher","first-page":"101814","DOI":"10.1016\/j.tranon.2023.101814","volume":"39","author":"G Marchi","year":"2024","unstructured":"Marchi, G. et al. Extensive mutational ctDNA profiles reflect High-grade serous cancer tumors and reveal emerging mutations at recurrence. Transl. Oncol. 39, 101814 (2024).","journal-title":"Transl. Oncol."},{"key":"74585_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010097","volume":"18","author":"A Bertolini","year":"2022","unstructured":"Bertolini, A. et al. scAmpi-A versatile pipeline for single-cell RNA-seq analysis from basics to clinics. PLoS Comput. Biol. 18, e1010097 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"74585_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"},{"key":"74585_CR38","doi-asserted-by":"publisher","first-page":"e0206785","DOI":"10.1371\/journal.pone.0206785","volume":"13","author":"AJ Shih","year":"2018","unstructured":"Shih, A. J. et al. Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq. PLoS ONE 13, e0206785 (2018).","journal-title":"PLoS ONE"},{"key":"74585_CR39","doi-asserted-by":"publisher","unstructured":"Kuipers, J., Tuncel, M. A., Ferreira, P. F., Jahn, K. & Beerenwinkel, N. Single-cell copy number calling and event history reconstruction. Bioinformatics 41, https:\/\/doi.org\/10.1093\/bioinformatics\/btaf072 (2025).","DOI":"10.1093\/bioinformatics\/btaf072"},{"key":"74585_CR40","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1126\/science.1198704","volume":"332","author":"SC Bendall","year":"2011","unstructured":"Bendall, S. C. et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332, 687\u2013696 (2011).","journal-title":"Science"},{"key":"74585_CR41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.2869","volume":"11","author":"C Giesen","year":"2014","unstructured":"Giesen, C. et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat. Methods 11, 417\u2013422 (2014).","journal-title":"Nat. Methods"},{"key":"74585_CR42","doi-asserted-by":"publisher","first-page":"e595","DOI":"10.1016\/S2352-3026(17)30208-9","volume":"4","author":"B Snijder","year":"2017","unstructured":"Snijder, B. et al. Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study. Lancet Haematol. 4, e595\u2013e606 (2017).","journal-title":"Lancet Haematol."},{"key":"74585_CR43","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1158\/2159-8290.CD-21-0538","volume":"12","author":"C Kornauth","year":"2022","unstructured":"Kornauth, C. et al. Functional precision medicine provides clinical benefit in advanced aggressive hematologic cancers and identifies exceptional responders. Cancer Discov. 12, 372\u2013387 (2022).","journal-title":"Cancer Discov."},{"key":"74585_CR44","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s43018-023-00544-9","volume":"4","author":"K Kropivsek","year":"2023","unstructured":"Kropivsek, K. et al. Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma. Nat. Cancer 4, 734\u2013753 (2023).","journal-title":"Nat. Cancer"},{"key":"74585_CR45","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283224","author":"JA Schmid","year":"2023","unstructured":"Schmid, J. A. et al. Efficacy and feasibility of pharmacoscopy-guided treatment for acute myeloid leukemia patients who have exhausted all registered therapeutic options. Haematologica https:\/\/doi.org\/10.3324\/haematol.2023.283224 (2023).","journal-title":"Haematologica"},{"key":"74585_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42101-z","volume":"14","author":"MHE Wildschut","year":"2023","unstructured":"Wildschut, M. H. E. et al. Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosis. Nat. Commun. 14, 6414 (2023).","journal-title":"Nat. Commun."},{"key":"74585_CR47","doi-asserted-by":"publisher","unstructured":"Gut, G., Herrmann, M. D. & Pelkmans, L. Multiplexed protein maps link subcellular organization to cellular states. Science 361, https:\/\/doi.org\/10.1126\/science.aar7042 (2018).","DOI":"10.1126\/science.aar7042"},{"key":"74585_CR48","doi-asserted-by":"publisher","unstructured":"Konecny, G. E. et al. Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer. J. Natl. Cancer Inst. 106, https:\/\/doi.org\/10.1093\/jnci\/dju249 (2014).","DOI":"10.1093\/jnci\/dju249"},{"key":"74585_CR49","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609\u2013615 (2011).","DOI":"10.1038\/nature10166"},{"key":"74585_CR50","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1158\/1078-0432.CCR-24-1594","volume":"31","author":"T Lanickova","year":"2025","unstructured":"Lanickova, T. et al. Chemotherapy drives tertiary lymphoid structures that correlate with ICI-responsive TCF1\u2009+\u2009CD8\u2009+\u2009T cells in metastatic ovarian cancer. Clin. Cancer Res. 31, 164\u2013180 (2025).","journal-title":"Clin. Cancer Res."},{"key":"74585_CR51","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05496-1","volume":"612","author":"I V\u00e1zquez-Garc\u00eda","year":"2022","unstructured":"V\u00e1zquez-Garc\u00eda, I. et al. Ovarian cancer mutational processes drive site-specific immune evasion. Nature 612, 778\u2013786 (2022).","journal-title":"Nature"},{"key":"74585_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00818-8","volume":"9","author":"E Stur","year":"2025","unstructured":"Stur, E. et al. The dynamic immune behavior of primary and metastatic ovarian carcinoma. NPJ Precis. Oncol. 9, 120 (2025).","journal-title":"NPJ Precis. Oncol."},{"key":"74585_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jbior.2015.10.009","volume":"60","author":"AP Fields","year":"2016","unstructured":"Fields, A. P., Justilien, V. & Murray, N. R. The chromosome 3q26 OncCassette: A multigenic driver of human cancer. Adv. Biol. Regul. 60, 47\u201363 (2016).","journal-title":"Adv. Biol. Regul."},{"key":"74585_CR54","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1158\/2159-8290.CD-15-0714","volume":"5","author":"PA Konstantinopoulos","year":"2015","unstructured":"Konstantinopoulos, P. A., Ceccaldi, R., Shapiro, G. I. & D\u2019Andrea, A. D. Homologous recombination deficiency: exploiting the fundamental vulnerability of ovarian cancer. Cancer Discov. 5, 1137\u20131154 (2015).","journal-title":"Cancer Discov."},{"key":"74585_CR55","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley, K. A. et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell 173, 291\u2013304 (2018).","journal-title":"Cell"},{"key":"74585_CR56","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen, R. & Seshan, V. E. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res. 44, e131 (2016).","journal-title":"Nucleic Acids Res."},{"key":"74585_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50137-y","volume":"15","author":"NL Burdett","year":"2024","unstructured":"Burdett, N. L. et al. Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer. Nat. Commun. 15, 6069 (2024).","journal-title":"Nat. Commun."},{"key":"74585_CR58","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/s41588-018-0179-8","volume":"50","author":"G Macintyre","year":"2018","unstructured":"Macintyre, G. et al. Copy number signatures and mutational processes in ovarian carcinoma. Nat. Genet. 50, 1262\u20131270 (2018).","journal-title":"Nat. Genet."},{"key":"74585_CR59","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s43018-023-00599-8","volume":"4","author":"X Zheng","year":"2023","unstructured":"Zheng, X. et al. Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer. Nat. Cancer 4, 1138\u20131156 (2023).","journal-title":"Nat. Cancer"},{"key":"74585_CR60","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm1831","volume":"8","author":"K Zhang","year":"2022","unstructured":"Zhang, K. et al. Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer. Sci. Adv. 8, eabm1831 (2022).","journal-title":"Sci. Adv."},{"key":"74585_CR61","doi-asserted-by":"publisher","first-page":"111181","DOI":"10.1016\/j.celrep.2022.111181","volume":"40","author":"C Cumin","year":"2022","unstructured":"Cumin, C. et al. Glycosphingolipids are mediators of cancer plasticity through independent signaling pathways. Cell Rep. 40, 111181 (2022).","journal-title":"Cell Rep."},{"key":"74585_CR62","first-page":"517","volume":"123","author":"RGW Verhaak","year":"2013","unstructured":"Verhaak, R. G. W. et al. Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. J. Clin. Invest. 123, 517\u2013525 (2013).","journal-title":"J. Clin. Invest."},{"key":"74585_CR63","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1158\/1078-0432.CCR-18-0784","volume":"24","author":"GM Chen","year":"2018","unstructured":"Chen, G. M. et al. Consensus on molecular subtypes of high-grade serous ovarian carcinoma. Clin. Cancer Res. 24, 5037\u20135047 (2018).","journal-title":"Clin. Cancer Res."},{"key":"74585_CR64","doi-asserted-by":"publisher","first-page":"7400","DOI":"10.1158\/1078-0432.CCR-17-0638","volume":"23","author":"D Hao","year":"2017","unstructured":"Hao, D. et al. Integrated analysis reveals tubal- and ovarian-originated serous ovarian cancer and predicts differential therapeutic responses. Clin. Cancer Res. 23, 7400\u20137411 (2017).","journal-title":"Clin. Cancer Res."},{"key":"74585_CR65","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.cell.2018.03.073","volume":"173","author":"AW Zhang","year":"2018","unstructured":"Zhang, A. W. et al. Interfaces of malignant and immunologic clonal dynamics in ovarian cancer. Cell 173, 1755\u20131769.e22 (2018).","journal-title":"Cell"},{"key":"74585_CR66","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1158\/1055-9965.EPI-18-1359","volume":"29","author":"M Schwede","year":"2020","unstructured":"Schwede, M. et al. The impact of stroma admixture on molecular subtypes and prognostic gene signatures in serous ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 29, 509\u2013519 (2020).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"74585_CR67","doi-asserted-by":"publisher","unstructured":"Waldron, L. et al. Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer. J. Natl. Cancer Inst. 106, https:\/\/doi.org\/10.1093\/jnci\/dju049 (2014).","DOI":"10.1093\/jnci\/dju049"},{"key":"74585_CR68","doi-asserted-by":"publisher","DOI":"10.1101\/2021.08.24.454519","author":"I V\u00e1zquez-Garc\u00eda","year":"2021","unstructured":"V\u00e1zquez-Garc\u00eda, I. et al. Immune and malignant cell phenotypes of ovarian cancer are determined by distinct mutational processes. BioRxiv https:\/\/doi.org\/10.1101\/2021.08.24.454519 (2021).","journal-title":"BioRxiv"},{"key":"74585_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.61","volume":"2","author":"UA Matulonis","year":"2016","unstructured":"Matulonis, U. A. et al. Ovarian cancer. Nat. Rev. Dis. Primers 2, 16061 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"74585_CR70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0092-8674(00)00010-6","volume":"102","author":"R Agami","year":"2000","unstructured":"Agami, R. & Bernards, R. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 102, 55\u201366 (2000).","journal-title":"Cell"},{"key":"74585_CR71","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1038\/onc.2010.245","volume":"29","author":"SL Cooke","year":"2010","unstructured":"Cooke, S. L. et al. Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma. Oncogene 29, 4905\u20134913 (2010).","journal-title":"Oncogene"},{"key":"74585_CR72","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/path.4105","volume":"229","author":"M Castellarin","year":"2013","unstructured":"Castellarin, M. et al. Clonal evolution of high-grade serous ovarian carcinoma from primary to recurrent disease. J. Pathol. 229, 515\u2013524 (2013).","journal-title":"J. Pathol."},{"key":"74585_CR73","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejca.2015.11.001","volume":"53","author":"S Lambrechts","year":"2016","unstructured":"Lambrechts, S. et al. Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer. Eur. J. Cancer 53, 51\u201364 (2016).","journal-title":"Eur. J. Cancer"},{"key":"74585_CR74","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/path.4230","volume":"231","author":"A Bashashati","year":"2013","unstructured":"Bashashati, A. et al. Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling. J. Pathol. 231, 21\u201334 (2013).","journal-title":"J. Pathol."},{"key":"74585_CR75","doi-asserted-by":"publisher","first-page":"6551","DOI":"10.1158\/0008-5472.CAN-17-1461","volume":"77","author":"X Yin","year":"2017","unstructured":"Yin, X. et al. Clonality, heterogeneity, and evolution of synchronous bilateral ovarian cancer. Cancer Res. 77, 6551\u20136561 (2017).","journal-title":"Cancer Res."},{"key":"74585_CR76","doi-asserted-by":"publisher","first-page":"E1974","DOI":"10.1073\/pnas.1216989110","volume":"110","author":"I Rizvi","year":"2013","unstructured":"Rizvi, I. et al. Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules. Proc. Natl. Acad. Sci. USA. 110, E1974\u2013E1983 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74585_CR77","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1158\/1078-0432.CCR-05-0462","volume":"11","author":"RJ Schilder","year":"2005","unstructured":"Schilder, R. J. et al. Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic Oncology Group Study. Clin. Cancer Res. 11, 5539\u20135548 (2005).","journal-title":"Clin. Cancer Res."},{"key":"74585_CR78","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1200\/JCO.2013.50.5669","volume":"32","author":"IB Vergote","year":"2014","unstructured":"Vergote, I. B. et al. Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup study. J. Clin. Oncol. 32, 320\u2013326 (2014).","journal-title":"J. Clin. Oncol."},{"key":"74585_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00463-z","volume":"7","author":"E \u00c5kerlund","year":"2023","unstructured":"\u00c5kerlund, E. et al. The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients. NPJ Precis. Oncol. 7, 111 (2023).","journal-title":"NPJ Precis. Oncol."},{"key":"74585_CR80","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413\u2013421 (2012).","journal-title":"Nat. Biotechnol."},{"key":"74585_CR81","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41588-018-0165-1","volume":"50","author":"CM Bielski","year":"2018","unstructured":"Bielski, C. M. et al. Genome doubling shapes the evolution and prognosis of advanced cancers. Nat. Genet. 50, 1189\u20131195 (2018).","journal-title":"Nat. Genet."},{"key":"74585_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-7-36","volume":"7","author":"DG Tiezzi","year":"2007","unstructured":"Tiezzi, D. G. et al. HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination. BMC Cancer 7, 36 (2007).","journal-title":"BMC Cancer"},{"key":"74585_CR83","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/00313020500465315","volume":"38","author":"DG Tiezzi","year":"2006","unstructured":"Tiezzi, D. G. et al. Apoptosis induced by neoadjuvant chemotherapy in breast cancer. Pathology 38, 21\u201327 (2006).","journal-title":"Pathology"},{"key":"74585_CR84","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/his.13272","volume":"71","author":"L Casey","year":"2017","unstructured":"Casey, L. et al. A comparison of p53 and WT1 immunohistochemical expression patterns in tubo-ovarian high-grade serous carcinoma before and after neoadjuvant chemotherapy. Histopathology 71, 736\u2013742 (2017).","journal-title":"Histopathology"},{"key":"74585_CR85","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/IGC.0000000000000108","volume":"24","author":"A G\u0105sowska-Bodnar","year":"2014","unstructured":"G\u0105sowska-Bodnar, A. et al. Survivin expression as a prognostic factor in patients with epithelial ovarian cancer or primary peritoneal cancer treated with neoadjuvant chemotherapy. Int. J. Gynecol. Cancer 24, 687\u2013696 (2014).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"74585_CR86","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1158\/2159-8290.CD-13-0285","volume":"4","author":"SM Dewhurst","year":"2014","unstructured":"Dewhurst, S. M. et al. Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov. 4, 175\u2013185 (2014).","journal-title":"Cancer Discov."},{"key":"74585_CR87","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg4521","volume":"381","author":"V Girish","year":"2023","unstructured":"Girish, V. et al. Oncogene-like addiction to aneuploidy in human cancers. Science 381, eadg4521 (2023).","journal-title":"Science"},{"key":"74585_CR88","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-020-03133-3","volume":"590","author":"RJ Quinton","year":"2021","unstructured":"Quinton, R. J. et al. Whole-genome doubling confers unique genetic vulnerabilities on tumour cells. Nature 590, 492\u2013497 (2021).","journal-title":"Nature"},{"key":"74585_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41805-6","volume":"14","author":"C Bao","year":"2023","unstructured":"Bao, C. et al. Genomic signatures of past and present chromosomal instability in Barrett\u2019s esophagus and early esophageal adenocarcinoma. Nat. Commun. 14, 6203 (2023).","journal-title":"Nat. Commun."},{"key":"74585_CR90","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1158\/1078-0432.CCR-21-1643","volume":"28","author":"Z Cheng","year":"2022","unstructured":"Cheng, Z. et al. The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma. Clin. Cancer Res. 28, 2911\u20132922 (2022).","journal-title":"Clin. Cancer Res."},{"key":"74585_CR91","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1074\/jbc.M511690200","volume":"281","author":"JA Knauf","year":"2006","unstructured":"Knauf, J. A. et al. Oncogenic RAS induces accelerated transition through G2\/M and promotes defects in the G2 DNA damage and mitotic spindle checkpoints. J. Biol. Chem. 281, 3800\u20133809 (2006).","journal-title":"J. Biol. Chem."},{"key":"74585_CR92","doi-asserted-by":"publisher","first-page":"38083","DOI":"10.1074\/jbc.274.53.38083","volume":"274","author":"HI Saavedra","year":"1999","unstructured":"Saavedra, H. I., Fukasawa, K., Conn, C. W. & Stambrook, P. J. MAPK mediates RAS-induced chromosome instability. J. Biol. Chem. 274, 38083\u201338090 (1999).","journal-title":"J. Biol. Chem."},{"key":"74585_CR93","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41586-023-06054-z","volume":"618","author":"F Mart\u00ednez-Jim\u00e9nez","year":"2023","unstructured":"Mart\u00ednez-Jim\u00e9nez, F. et al. Pan-cancer whole-genome comparison of primary and metastatic solid tumours. Nature 618, 333\u2013341 (2023).","journal-title":"Nature"},{"key":"74585_CR94","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1146\/annurev-cellbio-092910-154234","volume":"27","author":"T Davoli","year":"2011","unstructured":"Davoli, T. & de Lange, T. The causes and consequences of polyploidy in normal development and cancer. Annu. Rev. Cell Dev. Biol. 27, 585\u2013610 (2011).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"74585_CR95","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41588-023-01320-2","volume":"55","author":"NL Burdett","year":"2023","unstructured":"Burdett, N. L. et al. Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer. Nat. Genet. 55, 437\u2013450 (2023).","journal-title":"Nat. Genet."},{"key":"74585_CR96","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/s41586-022-05082-5","volume":"608","author":"T Baslan","year":"2022","unstructured":"Baslan, T. et al. Ordered and deterministic cancer genome evolution after p53 loss. Nature 608, 795\u2013802 (2022).","journal-title":"Nature"},{"key":"74585_CR97","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1158\/1078-0432.CCR-16-1469","volume":"23","author":"R Uppaluri","year":"2017","unstructured":"Uppaluri, R. et al. Biomarker and tumor responses of oral cavity squamous cell carcinoma to trametinib: a phase II neoadjuvant window-of-opportunity clinical trial. Clin. Cancer Res. 23, 2186\u20132194 (2017).","journal-title":"Clin. Cancer Res."},{"key":"74585_CR98","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1158\/1078-0432.CCR-10-2200","volume":"17","author":"AG Gilmartin","year":"2011","unstructured":"Gilmartin, A. G. et al. GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition. Clin. Cancer Res. 17, 989\u20131000 (2011).","journal-title":"Clin. Cancer Res."},{"key":"74585_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-025-01917-w","volume":"17","author":"L Nougarede","year":"2025","unstructured":"Nougarede, L., Hazane-Puch, F., de Fraipont, F., Jacquet, E. & Bidart, M. BRCA1 promoter methylation predicts PARPi response in ovarian cancer: insights from the KOMET study. Clin. Epigenetics 17, 140 (2025).","journal-title":"Clin. Epigenetics"},{"key":"74585_CR100","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature 541, 321\u2013330 (2017).","journal-title":"Nature"},{"key":"74585_CR101","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nbt.2696","volume":"31","author":"GM Frampton","year":"2013","unstructured":"Frampton, G. M. et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat. Biotechnol. 31, 1023\u20131031 (2013).","journal-title":"Nat. Biotechnol."},{"key":"74585_CR102","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"74585_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"74585_CR104","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"74585_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"74585_CR106","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/bioinformatics\/btm563","volume":"24","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P., Zhang, B. & Horvath, S. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics 24, 719\u2013720 (2008).","journal-title":"Bioinformatics"},{"key":"74585_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello, F. et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 11, 34 (2019).","journal-title":"Genome Med."},{"key":"74585_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18904-9","volume":"11","author":"Y Xuan","year":"2020","unstructured":"Xuan, Y. et al. Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studies. Nat. Commun. 11, 5248 (2020).","journal-title":"Nat. Commun."},{"key":"74585_CR109","doi-asserted-by":"publisher","first-page":"e10240","DOI":"10.15252\/msb.202110240","volume":"17","author":"J \u010cuklina","year":"2021","unstructured":"\u010cuklina, J. et al. Diagnostics and correction of batch effects in large-scale proteomic studies: a tutorial. Mol. Syst. Biol. 17, e10240 (2021).","journal-title":"Mol. Syst. Biol."},{"key":"74585_CR110","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry, S. T. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308\u2013311 (2001).","journal-title":"Nucleic Acids Res."},{"key":"74585_CR111","unstructured":"1000 Genomes Project Consortium. et al. A global reference for human genetic variation. Nature 526, 68\u201374 (2015)."},{"key":"74585_CR112","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1158\/1078-0432.CCR-17-3837","volume":"24","author":"OA Zill","year":"2018","unstructured":"Zill, O. A. et al. The landscape of actionable genomic alterations in cell-free circulating tumor DNA from 21,807 advanced cancer patients. Clin. Cancer Res. 24, 3528\u20133538 (2018).","journal-title":"Clin. Cancer Res."},{"key":"74585_CR113","doi-asserted-by":"publisher","first-page":"979","DOI":"10.12688\/f1000research.73600.1","volume":"10","author":"P-L Germain","year":"2021","unstructured":"Germain, P.-L., Lun, A., Macnair, W. & Robinson, M. D. Doublet identification in single-cell sequencing data using scDblFinder. F1000Res. 10, 979 (2021).","journal-title":"F1000Res."},{"key":"74585_CR114","doi-asserted-by":"publisher","first-page":"lqad058","DOI":"10.1093\/nargab\/lqad058","volume":"5","author":"M Prummer","year":"2023","unstructured":"Prummer, M. et al. scROSHI: robust supervised hierarchical identification of single cells. NAR Genom. Bioinform. 5, lqad058 (2023).","journal-title":"NAR Genom. Bioinform."},{"key":"74585_CR115","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"74585_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35519-4","volume":"13","author":"AE Murphy","year":"2022","unstructured":"Murphy, A. E. & Skene, N. G. A balanced measure shows superior performance of pseudobulk methods in single-cell RNA-sequencing analysis. Nat. Commun. 13, 7851 (2022).","journal-title":"Nat. Commun."},{"key":"74585_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1006-0","volume":"17","author":"R Catena","year":"2016","unstructured":"Catena, R., \u00d6zcan, A., Jacobs, A., Chevrier, S. & Bodenmiller, B. AirLab: a cloud-based platform to manage and share antibody-based single-cell research. Genome Biol. 17, 142 (2016).","journal-title":"Genome Biol."},{"key":"74585_CR118","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/cyto.a.24940","volume":"107","author":"R Casanova","year":"2025","unstructured":"Casanova, R. et al. Standardization of suspension and imaging mass cytometry readouts for clinical decision making. Cytometry A 107, 390\u2013403 (2025).","journal-title":"Cytometry A"},{"key":"74585_CR119","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.12688\/f1000research.26073.1","volume":"9","author":"HL Crowell","year":"2020","unstructured":"Crowell, H. L. et al. An R-based reproducible and user-friendly preprocessing pipeline for CyTOF data. F1000Res. 9, 1263 (2020).","journal-title":"F1000Res."},{"key":"74585_CR120","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","volume":"162","author":"JH Levine","year":"2015","unstructured":"Levine, J. H. et al. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis. Cell 162, 184\u2013197 (2015).","journal-title":"Cell"},{"key":"74585_CR121","doi-asserted-by":"publisher","first-page":"P10008","DOI":"10.1088\/1742-5468\/2008\/10\/P10008","volume":"2008","author":"VD Blondel","year":"2008","unstructured":"Blondel, V. D., Guillaume, J.-L., Lambiotte, R. & Lefebvre, E. Fast unfolding of communities in large networks. J. Stat. Mech. 2008, P10008 (2008).","journal-title":"J. Stat. Mech."},{"key":"74585_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75708-z","volume":"10","author":"A Levy-Jurgenson","year":"2020","unstructured":"Levy-Jurgenson, A., Tekpli, X., Kristensen, V. N. & Yakhini, Z. Spatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer. Sci. Rep. 10, 18802 (2020).","journal-title":"Sci. Rep."},{"key":"74585_CR123","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1109\/18.61115","volume":"37","author":"J Lin","year":"1991","unstructured":"Lin, J. Divergence measures based on the Shannon entropy. IEEE Trans. Inform. Theory 37, 145\u2013151 (1991).","journal-title":"IEEE Trans. Inform. Theory"},{"key":"74585_CR124","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1214\/aoms\/1177729694","volume":"22","author":"S Kullback","year":"1951","unstructured":"Kullback, S. & Leibler, R. A. On information and sufficiency. Ann. Math. Stat. 22, 79\u201386 (1951).","journal-title":"Ann. Math. Stat."},{"key":"74585_CR125","doi-asserted-by":"publisher","unstructured":"Ronneberger, O., Fischer, P. & Brox, T. U-Net: Convolutional networks for biomedical image segmentation. Preprint at https:\/\/doi.org\/10.48550\/arXiv.1505.04597 (2015).","DOI":"10.48550\/arXiv.1505.04597"},{"key":"74585_CR126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2005970","volume":"16","author":"C McQuin","year":"2018","unstructured":"McQuin, C. et al. CellProfiler 3.0: Next-generation image processing for biology. PLoS Biol. 16, e2005970 (2018).","journal-title":"PLoS Biol."},{"key":"74585_CR127","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nchembio.2360","volume":"13","author":"GI Vladimer","year":"2017","unstructured":"Vladimer, G. I. et al. Global survey of the immunomodulatory potential of common drugs. Nat. Chem. Biol. 13, 681\u2013690 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"74585_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter, A. E. et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100 (2006).","journal-title":"Genome Biol."},{"key":"74585_CR129","doi-asserted-by":"crossref","unstructured":"He, K., Zhang, X., Ren, S. & Sun, J. Deep residual learning for image recognition. In Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition (CVPR) 770\u2013778 (IEEE, 2016).","DOI":"10.1109\/CVPR.2016.90"},{"key":"74585_CR130","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41586-022-05028-x","volume":"608","author":"J Shilts","year":"2022","unstructured":"Shilts, J. et al. A physical wiring diagram for the human immune system. Nature 608, 397\u2013404 (2022).","journal-title":"Nature"},{"key":"74585_CR131","doi-asserted-by":"publisher","first-page":"e4712","DOI":"10.21769\/BioProtoc.4712","volume":"13","author":"BA Kramer","year":"2023","unstructured":"Kramer, B. A., Del Castillo, J. S., Pelkmans, L. & Gut, G. Iterative indirect immunofluorescence imaging (4i) on adherent cells and tissue sections. Bio Protoc 13, e4712 (2023).","journal-title":"Bio Protoc"},{"key":"74585_CR132","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/nmeth.2657","volume":"10","author":"N Battich","year":"2013","unstructured":"Battich, N., Stoeger, T. & Pelkmans, L. Image-based transcriptomics in thousands of single human cells at single-molecule resolution. Nat. Methods 10, 1127\u20131133 (2013).","journal-title":"Nat. Methods"},{"key":"74585_CR133","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF01908075","volume":"2","author":"L Hubert","year":"1985","unstructured":"Hubert, L. & Arabie, P. Comparing partitions. J. Classif. 2, 193\u2013218 (1985).","journal-title":"J. Classif."},{"key":"74585_CR134","doi-asserted-by":"publisher","unstructured":"Jacob, F. & Wegmann, R. A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy: scRNA-seq, CyTOF and IMC single-cell data [Data set]. Zenodo https:\/\/doi.org\/10.5281\/zenodo.19113819 (2026).","DOI":"10.5281\/zenodo.19113819"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74585-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74585-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74585-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:03:01Z","timestamp":1787097781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74585-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":134,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74585"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74585-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.B. has founded and is a shareholder and member of the board of Navignostics, a precision oncology spin-off from the University of Zurich. Personal Consultancy Fees as an Advisory Board member from Standard BioTools. B.S. was a scientific co-founder of Allcyte, which has been acquired by Exscientia. B.S. is a shareholder of Exscientia and a co-inventor on US patent application 15\/514,045 relevant to the study. L.P. and G.G. are listed as inventors on patents related to the 4i technology (WO 2019\/207004; WO 2020\/008071). G.R. is listed on a patent application related to single-cell analyses (European Patent Application No. 20170724.7) and is cofounder and on the Scientific Advisory Board of Computomics GmbH. H.M. is on advisory boards for Bayer, AstraZeneca, Janssen, Roche, and Merck. V.H.K is a participant of patent applications on the assessment of cancer biomarkers by digital pathology and reports being an invited speaker for Sharing Progress in Cancer Care (SPCC) and Indica Labs; advisory board of Takeda; sponsored research agreements with Roche and IAG, all unrelated to the current study. T.A.Z reports travel, honoraria from, and consulting role for AbbVie, unrelated to the current study. The Tumor Profiler study is jointly funded by a public-private partnership involving F. Hoffmann-La Roche Ltd., ETH Zurich, University of Zurich, University Hospital Zurich, and University Hospital Basel. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8624"}}